Showing 16,881 - 16,900 results of 104,954 for search '(( i wt decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.72s Refine Results
  1. 16881
  2. 16882

    Treatment adoption and diffusion pattern. by Frédéric Galacteros (11105678)

    Published 2023
    “…In clinical studies, voxelotor has been shown to increase hemoglobin (Hb) and decrease hemolytic markers in patients with SCD. The objective of this study was to estimate the impact of voxelotor on the burden of SCD in France using a modeling approach, accounting for its anticipated adoption and diffusion over the next 5 years. …”
  3. 16883
  4. 16884

    Patient clinical and histopathological data. by Henry Sossa-Rojas (15470838)

    Published 2023
    “…Therefore, the results suggest that RV Wt1-5 could be a novel therapeutic agent co-adjuvant agent for conventional and targeted therapies in managing GC. …”
  5. 16885

    S2 Text - by Henry Sossa-Rojas (15470838)

    Published 2023
    “…Therefore, the results suggest that RV Wt1-5 could be a novel therapeutic agent co-adjuvant agent for conventional and targeted therapies in managing GC. …”
  6. 16886

    S3 Text - by Henry Sossa-Rojas (15470838)

    Published 2023
    “…Therefore, the results suggest that RV Wt1-5 could be a novel therapeutic agent co-adjuvant agent for conventional and targeted therapies in managing GC. …”
  7. 16887

    Image3_Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas.TIF by Kai Sun (140584)

    Published 2024
    “…Bioinformatics analyses and luciferase reporter assays were performed and revealed targeted relationships between circ-CDK8 and miR-615-5p, miR-615-5p and SLC7A11. Interference with circ-CDK8 expression reduced SLC7A11 expression by sponging miR-615-5p, suppressed OSCC cell migration and invasion, and promoted ferroptosis by increasing ROS, MDA, and iron levels and decreasing GSH and GPX4 levels in OSCC cells. …”
  8. 16888

    Image1_Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas.TIF by Kai Sun (140584)

    Published 2024
    “…Bioinformatics analyses and luciferase reporter assays were performed and revealed targeted relationships between circ-CDK8 and miR-615-5p, miR-615-5p and SLC7A11. Interference with circ-CDK8 expression reduced SLC7A11 expression by sponging miR-615-5p, suppressed OSCC cell migration and invasion, and promoted ferroptosis by increasing ROS, MDA, and iron levels and decreasing GSH and GPX4 levels in OSCC cells. …”
  9. 16889

    Table1_Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas.DOCX by Kai Sun (140584)

    Published 2024
    “…Bioinformatics analyses and luciferase reporter assays were performed and revealed targeted relationships between circ-CDK8 and miR-615-5p, miR-615-5p and SLC7A11. Interference with circ-CDK8 expression reduced SLC7A11 expression by sponging miR-615-5p, suppressed OSCC cell migration and invasion, and promoted ferroptosis by increasing ROS, MDA, and iron levels and decreasing GSH and GPX4 levels in OSCC cells. …”
  10. 16890

    Image2_Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas.TIF by Kai Sun (140584)

    Published 2024
    “…Bioinformatics analyses and luciferase reporter assays were performed and revealed targeted relationships between circ-CDK8 and miR-615-5p, miR-615-5p and SLC7A11. Interference with circ-CDK8 expression reduced SLC7A11 expression by sponging miR-615-5p, suppressed OSCC cell migration and invasion, and promoted ferroptosis by increasing ROS, MDA, and iron levels and decreasing GSH and GPX4 levels in OSCC cells. …”
  11. 16891

    <i>Kif3a</i> controls expression of a <i>Fgf8</i>-mediated signaling pathway during nephron formation. by Lijun Chi (196000)

    Published 2013
    “…<p>A. Schematic of <i>Fgf8/Wnt4/Lim1</i> signaling pathway required during nephron formation. …”
  12. 16892

    Combustion Characteristics of C<sub>5</sub> Alcohols and a Skeletal Mechanism for Homogeneous Charge Compression Ignition Combustion Simulation by Sungwoo Park (1234614)

    Published 2015
    “…C<sub>5</sub> alcohol blending in PRF75 in HCCI combustion leads to a significant decrease of low-temperature heat release (LTHR) and a delay of the main combustion. …”
  13. 16893

    Combustion Characteristics of C<sub>5</sub> Alcohols and a Skeletal Mechanism for Homogeneous Charge Compression Ignition Combustion Simulation by Sungwoo Park (1234614)

    Published 2015
    “…C<sub>5</sub> alcohol blending in PRF75 in HCCI combustion leads to a significant decrease of low-temperature heat release (LTHR) and a delay of the main combustion. …”
  14. 16894

    Combustion Characteristics of C<sub>5</sub> Alcohols and a Skeletal Mechanism for Homogeneous Charge Compression Ignition Combustion Simulation by Sungwoo Park (1234614)

    Published 2015
    “…C<sub>5</sub> alcohol blending in PRF75 in HCCI combustion leads to a significant decrease of low-temperature heat release (LTHR) and a delay of the main combustion. …”
  15. 16895

    COVID19 effect on essential services. by Admas Abera (11821659)

    Published 2024
    “…The present study found that the mean number of patients treated for TB declined by 35 patients (β: -34.62; 95%CI: -50.29, -18.95) compared to the pre-COVID-19 era while the number of new patients enrolled for ART decreased by 71 patients (β: -70.62; 95%CI: -107.19, -34.05). …”
  16. 16896
  17. 16897

    Signed values between auditory oddball amplitudes of all time points and channels with <i>auditory</i> P300 BCI performance (defined as the number of sequences needed to reach 70%... by Sebastian Halder (283257)

    Published 2013
    “…<p>Two elements from the matrix were selected for visualization using scatter plots (B) showing a correlation of on electrode FC5 and a correlation of on electrode PO2. …”
  18. 16898

    Pre-treatment with GnRHa or <i>ulipristal acetate</i> prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis by Inge de Milliano (4515127)

    Published 2017
    “…Pre-treatment with GnRHa before laparoscopic myomectomies also shows a reduction in intra-operative blood loss by 23.03ml (95% CI -40.79 to -5.27) and in the frequency of blood transfusions (OR 0.17, 95% CI 0.05 to 0.55) compared to no pre-treatment.…”
  19. 16899
  20. 16900